Gurnet Point and Novo Holdings to acquire Paratek Pharmaceuticals for $462m

Oaktree Capital Management will provide $175 million in debt financing for this deal.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this